Bio-Key International Inc. (NASDAQ: BKYI)’s stock price has gone decline by -12.45 in comparison to its previous close of 0.96, however, the company has experienced a -22.22% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-09-23 that BIO-key, International (BKYI) Expands Deployment with Province of British Columbia, Adds 10,000 Biometric Users for Sign-on and Physical Access Control.
Is It Worth Investing in Bio-Key International Inc. (NASDAQ: BKYI) Right Now?
BKYI has 36-month beta value of 0.30. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for BKYI is 1.78M, and currently, short sellers hold a 15.71% ratio of that float. The average trading volume of BKYI on October 02, 2024 was 2.91M shares.
BKYI’s Market Performance
BKYI stock saw a decrease of -22.22% in the past week, with a monthly decline of -36.84% and a quarterly a decrease of -47.83%. The volatility ratio for the week is 11.69%, and the volatility levels for the last 30 days are 22.00% for Bio-Key International Inc. (BKYI). The simple moving average for the past 20 days is -34.98% for BKYI’s stock, with a -53.39% simple moving average for the past 200 days.
Analysts’ Opinion of BKYI
Many brokerage firms have already submitted their reports for BKYI stocks, with Maxim Group repeating the rating for BKYI by listing it as a “Buy.” The predicted price for BKYI in the upcoming period, according to Maxim Group is $6 based on the research report published on March 26, 2021 of the previous year 2021.
BKYI Trading at -38.30% from the 50-Day Moving Average
After a stumble in the market that brought BKYI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.86% of loss for the given period.
Volatility was left at 22.00%, however, over the last 30 days, the volatility rate increased by 11.69%, as shares sank -31.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.14% lower at present.
During the last 5 trading sessions, BKYI fell by -22.22%, which changed the moving average for the period of 200-days by -69.30% in comparison to the 20-day moving average, which settled at $1.2725. In addition, Bio-Key International Inc. saw -72.00% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BKYI starting from DEPASQUALE MICHAEL W, who purchase 20,000 shares at the price of $0.18 back on Dec 01 ’23. After this action, DEPASQUALE MICHAEL W now owns 306,827 shares of Bio-Key International Inc., valued at $3,600 using the latest closing price.
Sullivan James David, the Chief Legal Officer of Bio-Key International Inc., purchase 20,000 shares at $0.17 during a trade that took place back on Nov 30 ’23, which means that Sullivan James David is holding 388,171 shares at $3,300 based on the most recent closing price.
Stock Fundamentals for BKYI
Current profitability levels for the company are sitting at:
- -1.55 for the present operating margin
- 0.11 for the gross margin
The net margin for Bio-Key International Inc. stands at -1.5. The total capital return value is set at 12.16. Equity return is now at value -644.57, with -116.86 for asset returns.
Based on Bio-Key International Inc. (BKYI), the company’s capital structure generated 1.87 points at debt to capital in total, while cash flow to debt ratio is standing at -1.24. The debt to equity ratio resting at -2.15. The interest coverage ratio of the stock is -101.67.
Currently, EBITDA for the company is -8.24 million with net debt to EBITDA at -0.11. When we switch over and look at the enterprise to sales, we see a ratio of 0.44. The receivables turnover for the company is 6.52for trailing twelve months and the total asset turnover is 1.27. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.54.
Conclusion
To put it simply, Bio-Key International Inc. (BKYI) has had a bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
